#14,536
Yesterday in MMWR: Updated Guidance For Suspected Vaping-Related Lung Injury (EVALI) we looked at two early releases; one describing both hospitalized and non-hospitalized EVALI cases, and the other providing updated clinical guidance for diagnosis and treatment of confirmed or suspected cases.
Later today the CDC will hold a COCA Clinician Outreach Communication Activity) Call to bring clinicians up to speed on their latest findings and recommendations.Details on viewing today's COCA Call follow:
Update: Interim Guidance for Health Care Providers regarding the Management Approach of Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI)
Date: Thursday, November 21, 2019
Time: 2:00–3:00p.m. ET
Overview
CDC, the U.S. Food and Drug Administration (FDA), state and local health departments, and public health and clinical stakeholders continue to investigate a national outbreak of electronic cigarette (e-cigarette), or vaping, product use–associated lung injury (EVALI).
EVALI remains a diagnosis of exclusion because, at present, no specific test or marker exists for its diagnosis, and evaluation should be guided by clinical judgment. Because patients with EVALI can present with symptoms similar to influenza or other respiratory infections (e.g., fever, cough, headache, myalgias, or fatigue), it might be difficult to differentiate EVALI from influenza or CAP (community-acquired pneumonia) on initial presentation, and EVALI may cooccur with respiratory infections. A large number of patients will be presenting to healthcare facilities with respiratory symptoms during the winter season who may not meet criteria for hospital admission, and this will be happening in the context of a national outbreak of EVALI.
During this COCA Call, U.S. health care providers will learn recommendations for managing patients with suspected or known EVALI when respiratory infections such as influenza are more prevalent in the community, as published in MMWR on November 19, 2019.
Webinar Objectives
Call Materials
Presenters
Call Information
Additional Resources
A few minutes before the webinar begins, please click the below link to join: https://zoom.us/j/824203014external icon
Or join by iPhone one-tap : US: +16468769923,,824203014# or +16699006833,,824203014#
Or join by Telephone (for higher quality, dial a number based on your current location): Dial US: +1 646 876 9923 or +1 669 900 6833
Webinar ID: 824 203 014 International numbers are available: https://zoom.us/u/anixAVglV
Primarily of interest to clinicians and healthcare providers, these calls are designed to ensure that practitioners have up-to-date information for their practices. Older COCA calls are archived on the CDC Website, and are available for viewing.
